Ardisia Crenata: A New Source Of Health-Promoting Phytopharmaceuticals And Chemicals

Authors

  • Puja Saxena , Dr. Nripendra Singh, Surendra Kumar Singh

DOI:

https://doi.org/10.47750/pnr.2022.13.S10.595

Abstract

Both cell culture and preclinical animal model systems have been extensively studied to determine the effectiveness of natural plant metabolites utilized for human consumption. Some issues, including the inadequate systemic transport and bioavailability of promising medicines, contribute considerably to the divergence between these in vitro and in vivo benefits and their translation into clinical application. In the last several decades, scientists have made tremendous strides in effectively developing innovative drug delivery methods for encapsulating active plant metabolites. These systems include organic, inorganic, and hybrid nanoparticles. There are over 500 species of Ardisia (Myrsinaceae), and they may be found in both tropical and subtropical climates. Many different Ardisia species have been cultivated for their aesthetic value, culinary or medicinal properties, or both. Sometimes it is hard to tell whose species you are dealing with or where to get seeds or cuttings because of taxonomic ambiguities. The applications of Ardisia species or their phytochemical components have not been thoroughly studied. However, they are a rich source of new and physiologically powerful phytochemical substances like bergenin and artisan. This page provides an update on the clinical study into the use of Ardisia chemicals, as well as a summary of their historical use and current state of knowledge. This data also highlights the genus's potential as a source of medicinal medicines.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

Ardisia Crenata: A New Source Of Health-Promoting Phytopharmaceuticals And Chemicals. (2022). Journal of Pharmaceutical Negative Results, 4907-4914. https://doi.org/10.47750/pnr.2022.13.S10.595